Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical vancomycin and gentamicin for prevention of infection after ankle fracture fixation
ACTRN12621001655831Phase 3Not yet recruiting
- Sponsor
- Dr William O'Callaghan
- Start
- Jan 2022
- Modality
- Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of vancomycin and gentamicin in ankle fracture, sponsored by Dr William O'Callaghan. Planned start Jan 2022; status: not yet recruiting.
02
Drugs
vancomycingentamicin
03
Conditions
ankle fracture
Beyond the preview
Go deeper on ACTRN12621001655831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12621001655831.